Latest news
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - mykxlg.commykxlg.com · Sat, 08 Aug 2026 18:36:00 GMTARS PHARMACEUTICALS LAWSUIT ALERT: Bragar Eagel & Squire, - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 19:20:11 GMTARS PHARMACEUTICALS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm - lincolnjournal.comlincolnjournal.com · Fri, 07 Aug 2026 19:20:11 GMTARS Pharmaceuticals Inc (SPRY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 16:45:46 GMTBronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 16:00:00 GMTSPRY Deadline Alert: The Gross Law Firm Reminds ARS - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 14:21:00 GMTSPRY Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against ARS Pharmaceuticals Inc. - PR NewswirePR Newswire · Fri, 07 Aug 2026 11:21:00 GMTBronstein, Gewirtz & Grossman, LLC Is Investigating ARS Pharmaceu - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 04:12:34 GMT